Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Medical Oncology (Northwood, London, England)|July 22, 2025
Combination of PSMA targeting alpha-emitting radioligand [212Pb]Pb-AB001 with BET bromodomain inhibitors in in vitro prostate cancer modelsRugile Liukaityte, Vilde Yuli Stenberg, Andrius Kleinauskas, et al.
Scientific Reports|November 29, 2025
Cytotoxicity and cell cycle changes in prostate cancer cells with differing PSMA expression and p53 status after treatment with PSMA-targeting radioligand [212Pb]Pb-AB001Vilde Yuli Stenberg, Rugile Liukaityte, Sandra Kvarsvik Kristiansen, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2025
Therapeutic evaluation of [212Pb]Pb-AB001 and [177Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancerAnna Julie Kjøl Høyvik, Monika Kvassheim, Li-Wei Ma, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 3, 2025
Optimizing [212Pb]Pb-AB001 Radiopharmaceutical Therapy Schedules in PSMA-Positive Subcutaneous Prostate Cancer XenograftsAnna Julie Kjøl Høyvik, Vilde Yuli Stenberg, Rugile Liukaityte, et al.
Pageof 1